The Venture Codex Logo

The Venture Codex

Pureos Bioventures

Churerstrasse 47, Pfäffikon, 8808, Switzerland

Overview

Venture capital fund investing in innovative drug development companies.

Deals · 12mo

4

Links

WebsiteLinkedIn

Stage focus

Series A
Series B
Series C

Geographic focus

Denmark
France
Germany
Sweden
...

Sector focus

—

Investment portfolio

33rounds
NAMEDATESIZE
AnaCardio
Sep 2026Participated
$71 MSeries B
NovaGo Therapeutics
Sep 2026Led
$30 MSeries B
Tavo Biotherapeutics
Jun 2026Led
$17 MSeries A
Adcytherix
Oct 2025Participated
$122 MSeries A
Callio Therapeutics
Mar 2025Participated
$187 MSeries A
AnaCardio
Jan 2025Led
$21 MSeries A
Citryll
Dec 2024Participated
$99 MSeries B
Alentis Therapeutics
Nov 2024Participated
$181 MSeries D
Adcytherix
Jun 2024Participated
$32 MSeed
Memo Therapeutics
May 2024Participated
$22 MSeries C
Vico Therapeutics
Jan 2024Participated
$59 MSeries B
Memo Therapeutics
Nov 2023Led
$28 MSeries C
AnaCardio
Sep 2026Participated
$71 MSeries B
NovaGo Therapeutics
Sep 2026Led
$30 MSeries B
Tavo Biotherapeutics
Jun 2026Led
$17 MSeries A
Adcytherix
Oct 2025Participated
$122 MSeries A
Callio Therapeutics
Mar 2025Participated
$187 MSeries A
AnaCardio
Jan 2025Led
$21 MSeries A
Citryll
Dec 2024Participated
$99 MSeries B
Alentis Therapeutics
Nov 2024Participated
$181 MSeries D
Adcytherix
Jun 2024Participated
$32 MSeed
Memo Therapeutics
May 2024Participated
$22 MSeries C
Vico Therapeutics
Jan 2024Participated
$59 MSeries B
Memo Therapeutics
Nov 2023Led
$28 MSeries C
33
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Pureos Bioventures: 33 funding rounds are recorded in the selected participation categories.All available history.
Pureos Bioventures: 33 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed21
Series A46
Series B26
Series C+16
Other Equity22
Debt10

Monthly Deal Activity

Pureos Bioventures: 33 deals are recorded across 92 months.All available history.
Pureos Bioventures: 33 deals are recorded across 92 months. All available history
MonthDeals
Mar '191
Apr '190
May '191
Jun '190
Jul '191
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '201
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '201
Aug '200
Sep '202
Oct '201
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '211
Jun '211
Jul '210
Aug '210
Sep '210
Oct '210
Nov '211
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '221
Jun '222
Jul '220
Aug '220
Sep '221
Oct '221
Nov '220
Dec '221
Jan '230
Feb '230
Mar '231
Apr '232
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '231
Nov '231
Dec '230
Jan '241
Feb '240
Mar '240
Apr '240
May '241
Jun '241
Jul '240
Aug '240
Sep '240
Oct '240
Nov '241
Dec '241
Jan '251
Feb '250
Mar '251
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '251
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '261
Jul '260
Aug '260
Sep '262
Oct '260

Sector Breakdown

Pureos Bioventures: Health & Life Sciences is the largest displayed sector by deal count (33 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Pureos Bioventures: Health & Life Sciences is the largest displayed sector by deal count (33 deals). All available history
SectorDeals
Health & Life Sciences33
Manufacturing4
Networks, Cloud & Communication2
Space & Frontier Tech1

Deal Size Distribution

Pureos Bioventures: 33 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Pureos Bioventures: 33 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M10
$25M-$50M6
$50M-$100M8
$100M-$250M8
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Pureos Bioventures: Europe has the largest recorded deal count among the displayed regions (28 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Pureos Bioventures: Europe has the largest recorded deal count among the displayed regions (28 deals). All available history
RegionDeals
Europe28
United States4
Singapore1
Pureos Bioventures: 20 co-investors are shown, with Bpifrance sharing 8 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Pureos Bioventures: 20 co-investors are shown, with Bpifrance sharing 8 recorded deals. All available history
Co-investorShared deals
Bpifrance8
Novo Holdings8
EQT Life Sciences (LSP)6
Kurma Partners6
RA Capital Management5
Schroders Capital5
Adjuvant Capital4
Industrifonden4
Jeito Capital4
Polaris Partners4
Pontifax4
Redalpine4
Andera Partners3
Droia Ventures3
Sanofi Ventures3
Wellington Partners3
Ysios Capital3
4BIO Capital2
Alexandria Venture Investments2
BioMedPartners2

Investment Strategy

Pureos Bioventures: Led accounts for 36% and participating for 64% of round participation.All available history.
Pureos Bioventures: Led accounts for 36% and participating for 64% of round participation. All available history
CategoryDeals (count)Share (%)
Led1236%
Participating2164%
Pureos Bioventures: Single-lead accounts for 42% and co-led for 58% of lead dynamics.All available history.
Pureos Bioventures: Single-lead accounts for 42% and co-led for 58% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead542%
Co-led758%

Team

Dominik Escher

Managing Partner & Founding partner

Klaus Breiner

Managing Partner & Founding partner

Martin Münchbach

Managing Partner & Founding Partner

Ximing Ding

Investment Manager